TrialClinical lung cancer2021

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.

Taofeek K Owonikoko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.